Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort
Journal of Gastrointestinal and Liver Diseases · 2023
DOI: 10.15403/jgld-4893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2023. Verfasst von Andreas Teufel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Division of Clinical Bioinformatics, Dept. of Internal Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: Primary liver cancer (PLC) ranks among of the most common cancers worldwide. Within this group, a minority of cases displays characteristics of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), known as combined hepatocellular cholangiocarcinoma (cHCC- CCA). Currently, there is no specific standardized therapy for these mixed tumors. Therefore, the aim of our study was to analyze the clinical course, treatment and outcome of cHCC-CCA patients in a European population-based registry.
Methods
We investigated 9,144 patients with PLC (6,622 HCC, 2,356 iCCA, and 166 cHCC-CCA) diagnosed between 2009 and 2020. All data were obtained from Clinical Cancer Registry of Baden-Württemberg (BW), Germany.
Results
In all three groups patients were predominantly male (82%, 57%, and 68% for HCC, iCCA and cHCC-CCA groups, respectively). 48% of cHCC-CCA patients were diagnosed as stage IV cancers, which was more than for HCC (31%) but less compared to CCA (64%). Overall median survival of cHCC-CCA patients was worse compared to HCC (9-13 months vs. 15.5 months, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hepatology, Division of Clinical Bioinformatics, Dept. of Internal Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim; Clinical Cooperation Unit Healthy Metabolism, Center for Preventive…
- Division of Hepatology, Division of Clinical Bioinformatics, Dept. of Internal Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Isaac.Rodriguez@medma.uni-heidelberg.de.
- Clinical State Registration Office (KLR GmbH) of the Baden- Württemberg Cancer Registry, Stuttgart, Germany. Winzler@qualiko-bw.de.
- Clinical State Registration Office (KLR GmbH) of the Baden-Württemberg Cancer Registry, Stuttgart, Germany. Kokh@klr-krbw.de.
- Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden- Württemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim; Dept. of Medicine II, Medical Facult…
- Clinical State Registration Office (KLR GmbH) of the Baden- Württemberg Cancer Registry, Stuttgart, Germany. Surovtsova@klr-krbw.de.
Zitieren
APA
Teufel, A., Rodriguez, I., Winzler, C., Kokh, D., Ebert, M. P., Surovtsova, I., & Morakis, P. (2023). Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-4893
Vancouver
Teufel A, Rodriguez I, Winzler C, Kokh D, Ebert MP, Surovtsova I, et al. Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort. Journal of Gastrointestinal and Liver Diseases. 2023. doi:10.15403/jgld-4893
BibTeX
@article{Teufel2023,
author = {Teufel, Andreas and Rodriguez, Isaac and Winzler, Claudia and Kokh, Daria and Ebert, Matthias P and Surovtsova, Irina and Morakis, Philipp},
title = {Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2023},
doi = {10.15403/jgld-4893}
}
EUVIMED